1. CRC Screening and Quality of Colonoscopy

2. This program will include a discussion of investigational agents not approved by the FDA for use in the United States.

3. CRC: Overview

4. Development of CRC

5. Classification of Colorectal Polyps Conventional Adenomas

6. Characteristics of Conventional Adenomas

7. Conventional Adenomas

8. Classification of Colorectal Polyps Serrated Lesions

9. Classification of Colorectal Polyps Serrated Lesions

10. Characteristics of Serrated Lesions

11. Sessile Serrated Polyps

12. CRC Screening Defined

13. Approaches to CRC Screening

14. Approaches to Opportunistic CRC Screening

15. CRC Screening Tests: Overview

16. Fecal Immunochemical Test

17. FIT-Fecal DNA Test (Cologuard®)

18. Methylated Septin 9 DNA (Epi proColon®)

19. Colonoscopy

20. Flexible Sigmoidoscopy

21. MSTF Ranking of CRC Screening Tests

22. CRC Screening Recommendations for Average Risk Patients

23. Screening Recommendations for Patients With Family History of CRC

24. CRC Screening Role of PCP vs Gastroenterologist

25. Importance of Operator Skill in Colonoscopy

26. Adenoma Detection Rate

27. ADR and Risk of CRC or Death Kaiser Permanente Study

28. Factors That Impact ADR

29. Technologies That Can Aid Visualization of Adenomas

30. Electronic Chromoendoscopy With NBI

31. Chromoendoscopy With Methylene Blue MMX*

32. Fold-Flattening Devices

33. Conclusions

34. Abbreviations